Atlas Trials

Efficacy of FOLFOX+Bevacizumab in Combination With Irinotecan in the Treatment of Metastatic Colorectal Cancer

Clinical trial NCT01321957 · COMPLETED

Trial details

NCT number
NCT01321957
Sponsor
Martin-Luther-Universität Halle-Wittenberg
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Metastatic Colorectal Cancer
Start date
2011-05-01
Primary completion
2016-09-01
Enrollment
250

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.